Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Grifols (GRFS US)
Watchlist
5
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Grifols
•
12 Jun 2024 18:46
•
Syndicated
Grifols S A (GRFS) - Wednesday, Mar 13, 2024
Grifols, a biopharma company, has faced financial challenges but is making improvements and working towards a more stable future.
Value Investors Club
Follow
191 Views
Share
No more insights
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x